← Leaderboards
Elizabeth F. Neufeld
University Of California Los Angeles
$6,075,114
Attributed
$6,075,114
Total exposure
5
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $800.6K · FY2005–10$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$6,075,114 · 5
By mechanism
R01$5,699,566 · 3
R21$355,548 · 1
R13$20,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Gregory A. Brent$4,669,056
- Stephen D Cederbaum$1,561,049
- Ruben J. Boado$14,771,226
- Tracy Ruth Daniels-Wells$1,066,259
Others in their field
Top investigators on “Laboratory Mouse”
- Richard K. Wilson · Washington University$122,948,010
- Frank Patrick McCormick · University Of California San Francisco$87,382,096
- David Heimbrook · Leidos Biomedical Research, Inc.$81,904,667
- Kc Kent Lloyd · University Of California At Davis$56,148,943
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,869,943
- Carol J Bult · Jackson Laboratory$47,860,052
Research focus
Laboratory MouseEnzyme TherapyN AcetylglucosaminidaseDisease /Disorder ModelNonhuman Therapy EvaluationGenetically Modified AnimalsBone Marrow TransplantationGene TherapyGene ExpressionMucopolysaccharidosis Type IiiProteinsPathologyProceduresMouse ModelBrainCellsBaseEnzymesRecombinant ProteinsO GlycosidaseTechnology /Technique DevelopmentMicroarray TechnologyChimeric ProteinsDementia
Grant awards (18)
Molecular Studies of Sanfilippo Syndrome Type B$333,507
R01 · FY2010 · NS · contact PI
Molecular Studies of Sanfilippo Syndrome Type B$336,875
R01 · FY2009 · NS · contact PI
Aptamer-directed crossing of the blood barrier for enzyme therapy of LSDs$463,681
R01 · FY2008 · NS · contact PI
Molecular Studies of Sanfilippo Syndrome Type B$336,875
R01 · FY2008 · NS · contact PI
Aptamer-directed crossing of the blood barrier for enzyme therapy of LSDs$464,503
R01 · FY2007 · NS · contact PI
Aptamer-directed crossing of the blood barrier for enzyme therapy of LSDs$452,631
R01 · FY2006 · NS · contact PI
Aptamer-directed crossing blood barrier enzyme therapy$440,640
R01 · FY2005 · NS
Aptamer-directed crossing of BBB therapy of MPS 111B$178,352
R21 · FY2005 · NS
Molecular Studies of Sanfilippo Syndome type B$343,125
R01 · FY2004 · NS
Aptamer-directed crossing of BBB therapy of MPS 111B$177,196
R21 · FY2004 · NS
Molecular Studies of Sanfilippo Syndome type B$343,125
R01 · FY2003 · NS
ENZYME AND GENE THERAPY OF MPS I IN ANIMAL MODELS$391,960
R01 · FY2002 · DK
Molecular Studies of Sanfilippo Syndome type B$343,219
R01 · FY2002 · NS
ENZYME AND GENE THERAPY OF MPS I IN ANIMAL MODELS$380,031
R01 · FY2001 · DK
Molecular Studies of Sanfilippo Syndome type B$344,250
R01 · FY2001 · NS
Strategies for Therapy of MPS and Related Diseases$20,000
R13 · FY2001 · DK
ENZYME AND GENE THERAPY OF MPS I IN ANIMAL MODELS$363,297
R01 · FY2000 · DK
MOLECULAR STUDIES OF SANFILIPPO SYNDROME TYPE B$361,847
R01 · FY2000 · NS